Gossamer Bio, Inc.

GOSS

$10.94

Name : Gossamer Bio, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $66,913,316.00

EPSttm : -52.73

Gossamer Bio, Inc.

$10.94

0.09%

$0.01

GOSS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

16.94

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

11.04

EPS Last/This Y

43.68

EPS This/Next Y

0.7

Price

10.97

Target Price

82.48

Analyst Recom

2.43

Performance Q

-12.9

Upside

-17,910.3%

Beta

2.21

Ticker: GOSS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	GOSS	0.17	0.08	0.24	68032
2026-08-31	GOSS	0.1687	0.08	0.27	68155
2026-09-01	GOSS	0.1674	0.076642105926066	0.36293436293436	68384
2026-09-02	GOSS	0.1717	0.08	0.01	68710
2026-09-03	GOSS	0.1746	0.08	0.15	69208
2026-09-04	GOSS	0.177	0.08	0.00	69272
2026-09-08	GOSS	0.1791	0.08	0.01	69982
2026-09-09	GOSS	0.1596	0.08	0.23	69111
2026-09-10	GOSS	0.1429	0.08	1.69	69102
2026-09-11	GOSS	10.695	0.08	0.00	69119
2026-09-14	GOSS	10.845	0.08	0.25	68927
2026-09-15	GOSS	10.37	0.07	0.00	68100
2026-09-16	GOSS	11.03	0.07	0.00	68050
2026-09-17	GOSS	11.95	0.07	0.00	68015
2026-09-18	GOSS	10.86	0.07	0.00	67918
2026-09-21	GOSS	11.37	0.07	0.00	67323
2026-09-22	GOSS	11.8	0.07	0.00	67085
2026-09-23	GOSS	10.9	0.07	0.00	67056
2026-09-24	GOSS	10.94	0.07	0.00	67024
2026-09-25	GOSS	10.7	0.07	0.00	67024
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	GOSS	0.17	76.9	-	-0.18
2026-08-31	GOSS	0.17	76.9	-	-0.18
2026-09-01	GOSS	0.17	76.9	-	-0.18
2026-09-02	GOSS	0.17	76.9	-	-0.18
2026-09-03	GOSS	0.17	76.9	-	-0.18
2026-09-04	GOSS	0.18	76.9	-	-0.18
2026-09-08	GOSS	0.18	76.9	-	-0.18
2026-09-09	GOSS	0.16	76.9	-	-0.18
2026-09-10	GOSS	0.14	76.9	-	-0.18
2026-09-11	GOSS	10.69	76.9	-	-0.18
2026-09-14	GOSS	10.85	76.9	-	-14.40
2026-09-15	GOSS	10.36	76.9	-	-14.40
2026-09-16	GOSS	10.36	76.9	-	-14.40
2026-09-17	GOSS	11.96	76.9	-	-14.40
2026-09-18	GOSS	10.86	76.9	-	-16.32
2026-09-21	GOSS	11.31	76.9	-	-16.32
2026-09-22	GOSS	11.72	76.9	-	-16.32
2026-09-23	GOSS	10.94	76.9	-	-16.32
2026-09-24	GOSS	10.95	76.9	-	-16.32
2026-09-25	GOSS	10.97	76.9	-	-16.32
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	GOSS	0.00	10.46	19.36
2026-08-31	GOSS	0.00	10.47	19.36
2026-09-01	GOSS	0.00	10.47	19.36
2026-09-02	GOSS	0.00	10.47	19.36
2026-09-03	GOSS	0.00	10.47	19.36
2026-09-04	GOSS	0.00	10.47	19.36
2026-09-08	GOSS	0.00	10.43	19.36
2026-09-09	GOSS	0.00	10.43	19.36
2026-09-10	GOSS	0.00	10.43	19.36
2026-09-11	GOSS	0.00	10.43	18.43
2026-09-14	GOSS	0.00	0	17.16
2026-09-15	GOSS	0.00	0	18.44
2026-09-16	GOSS	0	0	16.91
2026-09-17	GOSS	0	0	16.91
2026-09-18	GOSS	0	0	16.91
2026-09-21	GOSS	0	0	18.44
2026-09-23	GOSS	0.00	0	18.44
2026-09-24	GOSS	0.00	0	18.44
2026-09-25	GOSS	0.00	0	16.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-16

Avg. EPS Est. Current Quarter

-3.89

Avg. EPS Est. Next Quarter

-4.96

Insider Transactions

Institutional Transactions

Beta

2.21

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.1

Max Drawdown 5-Year %

-99.1

Target Price

82.48

P/E

Forward P/E

PEG

P/S

1.25

P/B

P/Free Cash Flow

EPS

-55.67

Average EPS Est. Cur. Y

-16.32

EPS Next Y. (Est.)

-15.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-235

Relative Volume

1.19

Return on Equity vs Sector %

106.9

Return on Equity vs Industry %

126.5

EPS 1 7Days Diff

-1.9

EPS 1 30Days Diff

13.19

EBIT Estimation

◆ GOSS Healthcare

$10.94

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

18/25

Volume

4/15

Valuation

12/20

TP/AR

7/10

Options

8/10

RSI

42.3

Range 1M

13.1%

Sup Dist

3.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

20/30

Estimates

11/20

Inst/Vol

2/15

Options

6/10

EPS Yr

74%

EPS NY

32.7%

52W%

0.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +653.9% upside

Quality

8/30

Valuation

16/30

Growth

18/25

Stability

5/10

LT Trend

1/5

Upside

+653.9%

Quality

GOSS — P/E HistoricalBiotechnology

Gossamer Bio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 161

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

GOSS

Latest News

—

Caricamento notizie per GOSS…

stock quote shares GOSS – Gossamer Bio, Inc. Stock Price stock today

news today GOSS – Gossamer Bio, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch GOSS – Gossamer Bio, Inc. yahoo finance google finance

stock history GOSS – Gossamer Bio, Inc. invest stock market

stock prices GOSS premarket after hours

ticker GOSS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GOSS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y